Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Other Non-Current Assets (2022 - 2025)

Historic Other Non-Current Assets for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to $1.0 million.

  • Lucid Diagnostics' Other Non-Current Assets fell 1342.17% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 1342.17%. This contributed to the annual value of $1.1 million for FY2024, which is 4285.71% down from last year.
  • Lucid Diagnostics' Other Non-Current Assets amounted to $1.0 million in Q3 2025, which was down 1342.17% from $1.1 million recorded in Q2 2025.
  • Lucid Diagnostics' Other Non-Current Assets' 5-year high stood at $2.7 million during Q3 2023, with a 5-year trough of $695000.0 in Q1 2022.
  • Over the past 4 years, Lucid Diagnostics' median Other Non-Current Assets value was $1.4 million (recorded in 2024), while the average stood at $1.6 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 14834.53% in 2023, then crashed by 5570.64% in 2024.
  • Lucid Diagnostics' Other Non-Current Assets (Quarter) stood at $1.3 million in 2022, then surged by 48.84% to $2.0 million in 2023, then plummeted by 42.86% to $1.1 million in 2024, then decreased by 7.69% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q3 2025, $1.1 million for Q2 2025, and $1.1 million during Q1 2025.